IDH2 and oligodendroglioma: Besides, since low‐risk groups linked with longer survival rates, patients in the low‐risk group always prone to have less than 50% death, that is the main reason why there were no statistically differences between low‐risk and high‐risk groups in CGGA cohort with oligodendroglioma or IDH wild.